Impact of changed co-amoxiclav susceptibility testing formats on apparent resistance rates for bloodstream Escherichia coli in a long-term surveillance

Rosy A Reynolds; Shazad Mushtaq; Michael Allen; Carolyne Horner; Christopher Longshaw; David M Livermore

doi:10.1093/jac/dkab483

Impact of changed co-amoxiclav susceptibility testing formats on apparent resistance rates for bloodstream Escherichia coli in a long-term surveillance

Rosy A Reynolds, Shazad Mushtaq, Michael Allen, Carolyne Horner, Christopher Longshaw, David M Livermore^*

^*Corresponding author for this work

Research output: Contribution to journal › Article (Academic Journal) › peer-review

29 Downloads (Pure)

Original language	English
Article number	dkab483
Pages (from-to)	1206–1208
Number of pages	3
Journal	Journal of Antimicrobial Chemotherapy
Volume	77
Issue number	4
Early online date	19 Jan 2022
DOIs	https://doi.org/10.1093/jac/dkab483
Publication status	Published - 1 Apr 2022

Bibliographical note

Funding Information:
The BSAC Antimicrobial Resistance Surveillance Programme was wholly supported by the pharmaceutical industry. A list of companies that provided sponsorship throughout the Surveillance Programme is available at http://www.bsacsurv.org .

Access to Document

10.1093/jac/dkab483

Full-text PDF (author accepted manuscript)
This is the accepted author manuscript (AAM). The final published version (version of record) is available online via Oxford University Press at https://doi.org/10.1093/jac/dkab483. Please refer to any applicable terms of use of the publisher.
Accepted author manuscript, 550 KB

Handle.net

Persistent link

Cite this

@article{969b8a8cfc7b42a8b264967230d2e0c1,

title = "Impact of changed co-amoxiclav susceptibility testing formats on apparent resistance rates for bloodstream Escherichia coli in a long-term surveillance",

author = "Reynolds, {Rosy A} and Shazad Mushtaq and Michael Allen and Carolyne Horner and Christopher Longshaw and Livermore, {David M}",

note = "Funding Information: The BSAC Antimicrobial Resistance Surveillance Programme was wholly supported by the pharmaceutical industry. A list of companies that provided sponsorship throughout the Surveillance Programme is available at http://www.bsacsurv.org . ",

year = "2022",

month = apr,

day = "1",

doi = "10.1093/jac/dkab483",

language = "English",

volume = "77",

pages = "1206–1208",

journal = "Journal of Antimicrobial Chemotherapy",

issn = "0305-7453",

publisher = "Oxford University Press",

number = "4",

}

Impact of changed co-amoxiclav susceptibility testing formats on apparent resistance rates for bloodstream Escherichia coli in a long-term surveillance. / Reynolds, Rosy A; Mushtaq, Shazad; Allen, Michael et al.
In: Journal of Antimicrobial Chemotherapy, Vol. 77, No. 4, dkab483, 01.04.2022, p. 1206–1208.

Research output: Contribution to journal › Article (Academic Journal) › peer-review

TY - JOUR

T1 - Impact of changed co-amoxiclav susceptibility testing formats on apparent resistance rates for bloodstream Escherichia coli in a long-term surveillance

AU - Reynolds, Rosy A

AU - Mushtaq, Shazad

AU - Allen, Michael

AU - Horner, Carolyne

AU - Longshaw, Christopher

AU - Livermore, David M

N1 - Funding Information: The BSAC Antimicrobial Resistance Surveillance Programme was wholly supported by the pharmaceutical industry. A list of companies that provided sponsorship throughout the Surveillance Programme is available at http://www.bsacsurv.org .

PY - 2022/4/1

Y1 - 2022/4/1

U2 - 10.1093/jac/dkab483

DO - 10.1093/jac/dkab483

M3 - Article (Academic Journal)

C2 - 35045166

SN - 0305-7453

VL - 77

SP - 1206

EP - 1208

JO - Journal of Antimicrobial Chemotherapy

JF - Journal of Antimicrobial Chemotherapy

IS - 4

M1 - dkab483

ER -